Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents

Cannabis sativa L. is a plant that contains numerous chemically active compounds including cannabinoids such as trans-Δ-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), and flavone derivatives, such as luteolin-7-O-glucuronide and apigenin glucuronide. In particular, the polar fraction of hemp...

Full description

Bibliographic Details
Main Authors: Guillermo Cásedas, Cristina Moliner, Filippo Maggi, Eugenia Mazzara, Víctor López
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1009868/full
_version_ 1798001796064477184
author Guillermo Cásedas
Guillermo Cásedas
Cristina Moliner
Filippo Maggi
Eugenia Mazzara
Víctor López
Víctor López
author_facet Guillermo Cásedas
Guillermo Cásedas
Cristina Moliner
Filippo Maggi
Eugenia Mazzara
Víctor López
Víctor López
author_sort Guillermo Cásedas
collection DOAJ
description Cannabis sativa L. is a plant that contains numerous chemically active compounds including cannabinoids such as trans-Δ-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), and flavone derivatives, such as luteolin-7-O-glucuronide and apigenin glucuronide. In particular, the polar fraction of hemp including many phenolic compounds has been overlooked when compared with the more lipophilic fraction containing cannabinoids. Therefore, the aim of this study was to assess two extracts of industrial hemp (C. sativa) of different polarity (aqueous and hexane) by evaluating their antioxidant profile and their neuroprotective potential on pharmacological targets in the central nervous system (CNS). Several assays on in vitro antioxidant capacity (DPPH, superoxide radical, FRAP, ORAC), as well as inhibition of physiological enzymes such as acetylcholinesterase (AChE) and monoaminooxidase A (MAO-A) were carried out in order to find out how these extracts may be helpful to prevent neurodegenerative disorders. Neuro-2a cell line was selected to test the cytotoxic and neuroprotective potential of these extracts. Both extracts showed striking antioxidant capacity in the FRAP and ORAC assays, particularly the hexane extract, and interesting results for the DPPH and superoxide radical uptake assays, with the aqueous extract standing out especially in the latter. In enzyme inhibition assays, the aqueous extract showed AChE and MAO-A inhibitory activity, while the hexane extract only reached IC50 value for AChE inhibitory bioassay. Neuro-2a assays demonstrated that polyphenolic extract was not cytotoxic and exhibited cytoprotective properties against hydrogen peroxide and antioxidant response decreasing reactive oxygen species (ROS) production. These extracts could be a source of compounds with potential benefit on human health, especially related to neurodegenerative disorders.
first_indexed 2024-04-11T11:42:09Z
format Article
id doaj.art-5068beeb95fc421c948f29717864eb2f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T11:42:09Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-5068beeb95fc421c948f29717864eb2f2022-12-22T04:25:47ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.10098681009868Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agentsGuillermo Cásedas0Guillermo Cásedas1Cristina Moliner2Filippo Maggi3Eugenia Mazzara4Víctor López5Víctor López6Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, SpainInstituto Agroalimentario de Aragón-IA2 (CITA-Universidad de Zaragoza), Zaragoza, SpainDepartment of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, SpainSchool of Pharmacy, University of Camerino, Camerino, ItalySchool of Pharmacy, University of Camerino, Camerino, ItalyDepartment of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Zaragoza, SpainInstituto Agroalimentario de Aragón-IA2 (CITA-Universidad de Zaragoza), Zaragoza, SpainCannabis sativa L. is a plant that contains numerous chemically active compounds including cannabinoids such as trans-Δ-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), and flavone derivatives, such as luteolin-7-O-glucuronide and apigenin glucuronide. In particular, the polar fraction of hemp including many phenolic compounds has been overlooked when compared with the more lipophilic fraction containing cannabinoids. Therefore, the aim of this study was to assess two extracts of industrial hemp (C. sativa) of different polarity (aqueous and hexane) by evaluating their antioxidant profile and their neuroprotective potential on pharmacological targets in the central nervous system (CNS). Several assays on in vitro antioxidant capacity (DPPH, superoxide radical, FRAP, ORAC), as well as inhibition of physiological enzymes such as acetylcholinesterase (AChE) and monoaminooxidase A (MAO-A) were carried out in order to find out how these extracts may be helpful to prevent neurodegenerative disorders. Neuro-2a cell line was selected to test the cytotoxic and neuroprotective potential of these extracts. Both extracts showed striking antioxidant capacity in the FRAP and ORAC assays, particularly the hexane extract, and interesting results for the DPPH and superoxide radical uptake assays, with the aqueous extract standing out especially in the latter. In enzyme inhibition assays, the aqueous extract showed AChE and MAO-A inhibitory activity, while the hexane extract only reached IC50 value for AChE inhibitory bioassay. Neuro-2a assays demonstrated that polyphenolic extract was not cytotoxic and exhibited cytoprotective properties against hydrogen peroxide and antioxidant response decreasing reactive oxygen species (ROS) production. These extracts could be a source of compounds with potential benefit on human health, especially related to neurodegenerative disorders.https://www.frontiersin.org/articles/10.3389/fphar.2022.1009868/fulltrans-Δ-9-tetrahydrocannabinol (Δ9-THC)cannabidiol (CBD)cannabinoidpolyphenoloxidative stressantioxidant
spellingShingle Guillermo Cásedas
Guillermo Cásedas
Cristina Moliner
Filippo Maggi
Eugenia Mazzara
Víctor López
Víctor López
Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
Frontiers in Pharmacology
trans-Δ-9-tetrahydrocannabinol (Δ9-THC)
cannabidiol (CBD)
cannabinoid
polyphenol
oxidative stress
antioxidant
title Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
title_full Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
title_fullStr Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
title_full_unstemmed Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
title_short Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
title_sort evaluation of two different cannabis sativa l extracts as antioxidant and neuroprotective agents
topic trans-Δ-9-tetrahydrocannabinol (Δ9-THC)
cannabidiol (CBD)
cannabinoid
polyphenol
oxidative stress
antioxidant
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1009868/full
work_keys_str_mv AT guillermocasedas evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT guillermocasedas evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT cristinamoliner evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT filippomaggi evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT eugeniamazzara evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT victorlopez evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents
AT victorlopez evaluationoftwodifferentcannabissativalextractsasantioxidantandneuroprotectiveagents